Darunavir Tablet, Film Coated
Product Images NDC 70771-1745

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Darunavir (NDC 70771-1745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Darunavir 600 mg (1b288e91 Dedb 465d 8c45 Eb464dc72e89 01)

This text provides important information about Darunavir tablets. Each film-coated tablet contains 600 mg of Darunavir. The package is child-resistant. The storage temperature is recommended between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It also mentions not to take certain medicines with Darunavir tablets. This product is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India.*

FDA Label Image

Darunavir 800 mg (1b288e91 Dedb 465d 8c45 Eb464dc72e89 02)

This is a description of Darunavir tablets, with each film-coated tablet containing 800 mg of Darunavir. The package is child-resistant and should be stored at 20°C to 25°C, with excursions permitted between 15°C to 30°C. It is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India. The text also mentions caution regarding medicines that should not be taken with Darunavir tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.